Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling

Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease globally. NAFLD—which can develop into liver fibrosis, nonalcoholic steatohepatosis, cirrhosis, and hepatocellular carcinoma—is defined as an excess accumulation of fat caused by abnormal lipid metabolism and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mi Hye, Seong, Jung Bae, Huh, Jae-Won, Bae, Yong Chul, Lee, Hyun-Shik, Lee, Dong-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736789/
https://www.ncbi.nlm.nih.gov/pubmed/31505325
http://dx.doi.org/10.1016/j.redox.2019.101315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736789/
https://www.ncbi.nlm.nih.gov/pubmed/31505325
http://dx.doi.org/10.1016/j.redox.2019.101315

Ejemplares similares